431
Participants
Start Date
February 28, 2005
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)
Abatacept, intravenous (IV) Solution, Infusion, Depends on participant weight, Monthly, 12 months.
Infliximab (INF) + MTX, DB
Infliximab, IV Solution, Infusion, Depends on participant weight, Every 2 Months, 12 months.
Placebo (PLA) + MTX, DB
Placebo, IV Solution, Infusion, Depends on participant weight, Monthly, 6 months.
PLA + MTX switched to ABA+ MTX, DB
Placebo=IV Solution, Infusion, Depends on participant weight, Monthly, 6 months. Abatacept=IV Solution, Infusion, Depends on participant weight, Monthly, 6 months
ABA, open-label (OL)
Abatacept, IV solution, Infusion. Depends on participant weight, Monthly, 12+ months
Local Institution, Huntsville
Local Institution, Denver
Local Institution, Boca Raton
Local Institution, Fort Lauderdale
Local Institution, Largo
Local Institution, Indianapolis
Local Institution, New Orleans
Local Institution, Springfield
Local Institution, Worcester
Local Institution, Flowood
Local Institution, Syracuse
Local Institution, Charlotte
Local Institution, Cincinnati
Local Institution, Oklahoma City
Local Institution, Tulsa
Local Institution, Bethlehem
Local Institution, Willow Grove
Local Institution, Austin
Local Institution, Dallas
Local Institution, Buenos Aires
Local Institution, Capital Federal
Local Institution, Quilmes
Local Institution, Córdoba
Local Institution, San Miguel de Tucumán
Local Institution, Cairns
Local Institution, Cotton Tree
Local Institution, Clayton
Local Institution, Heidelberg
Local Institution, Malvern
Local Institution, Parkville
Local Institution, Perth
Local Institution, Curitiba
Local Institution, Recife
Local Institution, Rio de Janeiro
Local Institution, Porto Alegre
Local Institution, São Paulo
Local Institution, Calgary
Local Institution, Edmonton
Local Institution, Winnipeg
Local Institution, St. John's
Local Institution, Hamilton
Local Institution, Kitchener
Local Institution, Ottawa
Local Institution, Montreal
Local Institution, Ste-Foy
Local Institution, Saskatoon
Local Institution, Prague
Local Institution, Copenhagen
Local Institution, Tijuana
Local Institution, León
Local Institution, Guadalajara
Local Institution, Mexico City
Local Institution, Monterrey
Local Institution, San Luis Potosí City
Local Institution, Lima
Local Institution, Poznan
Local Institution, Sopot
Local Institution, Warsaw
Local Institution, Rio Piedras
Local Institution, Moscow
Local Institution, Muckleneuk
Local Institution, Berea
Local Institution, Panorama
Local Institution, Seoul
Local Institution, A Coruña
Local Institution, Barcelona
Local Institution, Córdoba
Local Institution, Madrid
Local Institution, Falun
Local Institution, Linköping
Local Institution, Lund
Local Institution, Stockholm
Local Institution, Uppsala
Local Institution, Bern
Local Institution, Sankt Gallen
Local Institution, Kitchener
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY